Vonoprazan-based Helicobacter pylori (H. pylori) treatment is highly effective in eradicating the target bacteria; however, its post-1-year impact on gut microbiota is unknown. This study evaluated the impact of vonoprazan-based H. pylori therapy on gut microbiota 1-year post-therapy and investigated the relationship between body weight changes and post-therapy gut microbiota perturbations.

中文翻译：

---

基于vonoprazan的幽门螺杆菌治疗对肠道微生物群的长期影响及其与治疗后体重变化的关系

基于 Vonoprazan 的幽门螺杆菌( H. pylori ) 治疗对根除目标细菌非常有效；然而，其 1 年后对肠道微生物群的影响尚不清楚。本研究评估了基于 vonoprazan 的幽门螺杆菌治疗对治疗后 1 年肠道微生物群的影响，并调查了体重变化与治疗后肠道微生物群扰动之间的关系。